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central hyperdensity on CT is most likely explained by the patho-
logic finding of a dense, tenacious substance filling the center of
the mass. Distinguishing features between mitral annular abscess
and caseous calcification include the lack of larger amounts of
calcification in the case of mitral abscesses.4 A cardiac tumor can
be ruled out on CT by the lack of soft-tissue density and absence
of contrast enhancement.
In summary, caseous calcification represents a rare, underap-
preciated variant of mitral annular calcification that should be
differentiated from an abscess or tumor. It is likely that the
growing clinical use of cardiac CT may increasingly uncover this
rare entity.
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Giant metastatic myxoid liposarcoma of the mediastinum: A case report
Gabriele Di Giammarco, MD, Michele Di Mauro, MD, Marco Pano, MD, Sergio Cirmeni, MD, Marco Contini, MD,
Carlo Di Lorenzo, MD, Antonio Bivona, MD, and Gerardo Liberti, MD, Chieti, Italy
Myxoid liposarcoma is a very uncommon primaryneoplasm in the mediastinum, representing 9%of all primary sarcomas in this area.1,2 It devel-ops preferentially in the lower extremities (75%)
and less frequently in the retroperitoneum.1 Myxoid liposar-
coma usually metastasizes in the lungs and bone,1 and rarely in
the mediastinum.3 The time interval between the first presen-
tation and the pericardial metastasis ranges from 7 to 25 years.1
A case of giant metastatic myxoid liposarcoma in the pericar-
dium causing cardiac tamponade is reported.
Clinical Summary
A 62-year-old man underwent 3 resections of a primary myxoid
liposarcoma of the left thigh in 1983, 1985, and 1989. He was
admitted to the hospital with reports of dyspnea for the previous 3
weeks and chest pain of recent onset. The computed tomography
(CT) scan performed 6 months previously at a follow-up exami-
nation did not show any metastasis. No abnormalities were evident
on the electrocardiogram. The chest radiography revealed a wid-
ened mediastinum. Echocardiography showed a big mass in the
pericardium compressing the right sections of the heart. The CT
scan confirmed the presence of a mediastinal mass with dimen-
sions of 23.5  18.0  15.0 cm (Figure 1). On the same day, the
patient underwent surgical resection.
After the chest was opened through a median sternotomy, the
pericardium appeared very tense and consistently hard. The peri-
cardium was incised, starting from a cranial point where the
surface was less tense. Soon after, we noticed that the inferior
surface of the heart was displaced cranially to the mid-transverse
line of the anterior mediastinum. The majority of the pericardium
was occupied by the neoplasm, and the heart appeared undersized.
The tumor was free from adhesions throughout the entire circum-
ference except for a small area infiltrating the inferior wall of the
right ventricle close to the apex. Cardiopulmonary bypass was
established with both venae cavae cannulated. Myocardial protec-
tion was achieved by intermittent antegrade warm blood cardio-
plegia. The mass was easily dissected from the diaphragm. The
infiltrating area was extensively resected over normal muscle, and
the ventriculotomy was repaired with an equine pericardial patch
(8.0  6.0 cm) (Edwards LifeSciences LLC, Irvine, Calif) sutured
with a running 4-0 Prolene suture (Ethicon, Somerville, NJ).
The patient had an uneventful postoperative recovery and was
discharged on the fifth postoperative day. The first CT did not
show any recurrence of the tumor.
The resected mass measured 21.0  17.0  15.0 cm and
weighed 2430 g. It was yellowish and mainly encapsulated except
for the infiltrating area. The cut surface revealed myxoid and
necrotic areas. Microscopy showed prevalent myxoid stroma con-
taining lipoblasts and myocytes in the infiltrating area (Figure 2).
It was labeled grade I, with the percentage of round cells less than
10%.1
Discussion
Wong and colleagues4 reported a case of a 54-year-old patient with
a previously resected liposarcoma of the left pectoralis muscle who
underwent operation for a metastatic tumor located in the anterior
mediastinum and measuring 18  14 cm. They stated that the
From the Division of Cardiac Surgery, University “G D’Annunzio,” Chieti-
Pescara, Chieti, Italy.
Received for publication Dec 10, 2004; accepted for publication Jan 10,
2005.
Address for reprints: Gabriele Di Giammarco, MD, Chief of Division of
Cardiac Surgery, University “G D’Annunzio,” S Camillo Hospital, v For-
lanini 50, 66100 Chieti, Italy (E-mail: gabriele.digiammarco1@tin.it).
J Thorac Cardiovasc Surg 2005;129:1440-2
0022-5223/$30.00
Copyright © 2005 by The American Association for Thoracic Surgery
doi:10.1016/j.jtcvs.2005.01.010
Brief Communications
1440 The Journal of Thoracic and Cardiovascular Surgery ● June 2005
excised mass was the biggest mediastinal metastatic myxoid lipo-
sarcoma ever reported.
Myxoid liposarcoma has an expansive rather than infiltrative
growth, so it can cause symptoms because of compression of the
heart and great vessels.4 Symptoms are dyspnea, wheezing, and
chest pain, even if the tumor grows asymptomatically.2
In our case, the patient stayed asymptomatic until 3 weeks
before surgery, with a negative CT scan 6 months before. This
means the described metastasis occurred long after the first pre-
sentation of the primary tumor (21 years), but developed in less
than 6 months.
Although the operative mortality ranges from 12% to
40%,2,5 surgical resection remains the only chance in these rare
cases.
Patients with myxoid liposarcoma who are surgically treated
demonstrate good survival even 10 years after surgery. Multivar-
iate analysis individuated the presence of round cells, age (45
years), and necrotic areas as independent variables for a lower
survival at 10 years; the grade of the neoplasm influences the
incidence of metastasis and its recurrence.1
Patients with deep-seated liposarcoma more frequently have
recurrences within 6 months; the main negative factor is an in-
complete resection.1
In our case, evidence of necrotic areas within the mass and age
more than 45 years have to be considered unfavorable prognostic
factors, but the low-grade round cells differentiation and complete
resection of the tumor could provide a good survival free of
recurrences.
Conclusions
Our case can be considered unique for the giant dimensions and
rare location of the metastasis. Complete surgical resection repre-
Figure 1. Preoperative computed tomography (CT) scan showed a mediastinal mass with dimensions of 23.5 18.0
 15.0 cm. Ao, Aorta; RA, right atrium; PA, pulmonary artery; LA, left atrium; RV, right ventricle; LV, left ventricle.
Figure 2. Cut surface revealed myxoid and necrotic areas (A). Histologic section of the infiltrating area (hema-
toxylin-eosin, 10) demonstrated a myxoid stroma containing lipoblasts and myocytes (B). G, Gelatinous; N,
necrotic.
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sents the only chance to improve survival and quality of life in
these rare cases.
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Mechanical aortic valve malfunction: An intraoperative BioGlue
complication
Mohsen Karimi, MD,a Richard E. Kerber, MD,b and Jeffrey E. Everett, MD,a Iowa City, Iowa
We report a case of intraoperative mechanical aorticvalve malfunction after application of BioGlue(Cryolife, Inc, Kennesaw, Ga) over the aortotomyclosure.
Clinical Summary
A 62-year-old woman, weighing 48 kg, with symptomatic com-
bined aortic stenosis and insufficiency presented for elective valve
replacement.
After median sternotomy, the aorta was cannulated, and a
single dual-stage venous cannula was placed through the right
atrial appendage. Antegrade and retrograde cold blood cardiople-
gia with moderate core hypothermia (32°C) constituted the car-
dioprotective strategy. The left ventricle was vented through the
right superior pulmonary vein. Exposure of the aortic valve was
obtained through a transverse aortotomy. The valve was severely
calcified. The valve was excised in its entirety and calcium debrided.
The patient’s native root was small, and the annulus size was 19 mm.
A 19-mm St Jude Regent Mechanical valve (St Jude Medical, Inc, St
Paul, Minn) was chosen because it would provide acceptable hemo-
dynamics. The valve was seated into position successfully, and each
of the leaflets moved freely. The aortotomy was next closed in 2
layers with 4-0 Prolene suture (Ethicon, Inc, Somerville, NJ). The
suture line was checked for integrity with administration of cardio-
plegia in antegrade fashion. The closure appeared hemostatic with the
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Figure 1. Aortic insufficiency after BioGlue (Cryolife, Inc, Kenne-
saw, Ga) application.
Figure 2. Restoration of valve function after removal of BioGlue.
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